Skip to main content

Advertisement

Log in

Recurrence and graft loss after renal transplantation in adults with IgA vasculitis

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

IgA vasculitis, a rare condition resulting in end-stage renal disease, is a small-vessel vasculitis that affects the kidney in 49–83 % of adults. The reported recurrence rate of IgA vasculitis in renal transplant recipients is 11.5–60 %, leading to graft loss in 0–50 % of these patients. However, limited data are available on recurrence and graft loss after renal transplantation.

Methods

We evaluated renal transplant recipients seen from 1987 to 2015 at the Jikei University School of Medicine and the Department of Urology, Tokyo Women’s Medical University. Using a 1:2 match, 21 patients with IgA vasculitis and 42 controls were selected. The mean post-transplant follow-up was 121 ± 69 months for IgA vasculitis and 147 ± 66 months for the controls.

Results

The 15-year patient survival was 100 % in IgA vasculitis and 97.6 % in the controls (p = 0.22). The 5-, 10-, and 15-year graft survival rates were 95.2, 90.5, and 81 % in IgA vasculitis and 100, 90.5, and 88.1 % in the controls, respectively (p = 0.63). The recurrence rate was 28.6 % (6 of 21 cases) and half of them (3 of 6 cases) showed histological activity (ISKDC III). We treated them with methylprednisolone pulse therapy and/or tonsillectomy. None of the recurrence cases lost the allograft.

Conclusion

The long-term patient and graft survival of IgA vasculitis in renal transplantation were comparable with the previous reports. The recurrence rate was 28.6 %, but none of the recurrent cases showed allograft loss in this study. We speculate that methylprednisolone pulse therapy and/or tonsillectomy prevent the progression of recurrent IgA vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271–8.

    Article  PubMed  Google Scholar 

  2. Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Shönlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14(7):579–85.

    Article  CAS  PubMed  Google Scholar 

  3. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr. 1988;147(2):113–5.

    Article  CAS  PubMed  Google Scholar 

  4. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet. 2002;360(9334):666–70.

    Article  PubMed  Google Scholar 

  5. Samuel JP, Bell CS, Molony DA, Braun MC. Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura. Clin J Am Soc Nephrol. 2011;6(8):2034–40.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kellerman PS. Henoch-Schönlein purpura in adults. Am J Kidney Dis. 2006;48(6):1009–16.

    Article  PubMed  Google Scholar 

  7. Kanaan N, Mourad G, Thervet E, Peeters P, Hourmant M, Vanrenterghem Y, De Meyer M, Mourad M, Maréchal C, Goffin E, Pirson Y. Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis. Clin J Am Soc Nephrol. 2011;6(7):1768–72.

    Article  PubMed  Google Scholar 

  8. Thervet E, Aouizerate J, Noel LH, Brocheriou I, Martinez F, Mamzer MF, Legendre C. Histologic recurrence of Henoch-Schonlein Purpura nephropathy after renal transplantation on routine allograft biopsy. Transplantation. 2011;92(8):907–12.

    Article  PubMed  Google Scholar 

  9. Han SS, Sun HK, Lee JP, Ha JW, Kim SJ, Kim YS. Outcome of renal allograft in patients with Henoch-Schönlein nephritis: single-center experience and systematic review. Transplantation. 2010;89(6):721–6.

    Article  PubMed  Google Scholar 

  10. Moroni G, Gallelli B, Diana A, Carminati A, Banfi G, Poli F, Montagnino G, Tarantino A, Messa P. Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome. Nephrol Dial Transplant. 2008;23(9):3010–6.

    Article  PubMed  Google Scholar 

  11. Ohara S, Kawasaki Y, Matsuura H, Oikawa T, Suyama K, Hosoya M. Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch-Schönlein purpura nephritis and persistent nephrotic syndrome. Clin Exp Nephrol. 2011;15(5):749–53.

    Article  PubMed  Google Scholar 

  12. Lee J, Clayton F, Shihab F, Goldfarb-Rumyantzev A. Successful treatment of recurrent Henoch-Schönlein purpura in a renal allograft with plasmapheresis. Am J Transplant. 2008;8(1):228–31.

    CAS  PubMed  Google Scholar 

  13. Iwazu Y, Akimoto T, Muto S, Kusano E. Clinical remission of Henoch-Schönlein purpura nephritis after a monotherapeutic tonsillectomy. Clin Exp Nephrol. 2011;15(1):132–5.

    Article  PubMed  Google Scholar 

  14. Kanai H, Sawanobori E, Kobayashi A, Matsushita K, Sugita K, Higashida K. Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric henoch-schönlein purpura nephritis in children. Nephron Extra. 2011;1(1):101–11.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sugiyama H, Watanabe N, Onoda T, Kikumoto Y, Yamamoto M, Maeta M, Ohara N, Maeshima Y, Yamasaki Y, Makino H. Successful treatment of progressive Henoch-Schönlein purpura nephritis with tonsillectomy and steroid pulse therapy. Intern Med. 2005;44(6):611–5.

    Article  PubMed  Google Scholar 

  16. Tayabali S, Andersen K, Yoong W. Diagnosis and management of Henoch-Schönlein purpura in pregnancy: a review of the literature. Arch Gynecol Obstet. 2012;286(4):825–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We appreciate the support provided by Katsunori Shimada, PhD. (STATZ Institute, Inc., Tokyo, Japan), who provided expert assistance with statistical analysis.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Izumi Yamamoto.

Ethics declarations

Conflict of interest

None of the authors have any of conflicts of interest to declare with regard to the content of this article.

Funding

Astellas Pharma Inc. (Tokyo, Japan) supported this study with a grant. The sponsor was not involved in the study design, patient enrollment, data collection, analysis, or interpretation, or preparation of the manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB Approval Number 28-003) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawabe, M., Yamamoto, I., Komatsuzaki, Y. et al. Recurrence and graft loss after renal transplantation in adults with IgA vasculitis. Clin Exp Nephrol 21, 714–720 (2017). https://doi.org/10.1007/s10157-016-1336-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-016-1336-y

Keywords

Navigation